Study Comparing a Pantoprazole Formulation to the Currently Marketed Tablet for GERD and Erosive Esophagitis

NCT00195208 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

97

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastroesophageal Reflux
Esophagitis

Interventions

DRUG: Pantoprazole for approximately 9 weeks

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer